Related Experiment Videos
Association between HLA-Cw*0602 polymorphism and psoriasis risk: a meta-analysis
Genetics and Molecular Research : GMR
|December 24, 2011
Summary
The human leukocyte antigen (HLA) Cw*0602 polymorphism is a significant risk factor for developing psoriasis. This genetic variant increases the likelihood of developing psoriasis, as confirmed by a comprehensive meta-analysis.
Area of Science:
- Immunogenetics
- Dermatology
- Genetic Epidemiology
Background:
- Psoriasis is a chronic inflammatory skin disease with a complex etiology.
- The human leukocyte antigen (HLA) Cw*0602 polymorphism has been investigated as a potential genetic risk factor for psoriasis.
- Previous studies on the association between HLA-Cw*0602 and psoriasis risk have yielded inconsistent results.
Purpose of the Study:
- To conduct a meta-analysis to clarify the association between HLA-Cw*0602 polymorphism and psoriasis risk.
- To provide a pooled estimate of the risk conferred by HLA-Cw*0602 in a large cohort.
Main Methods:
- A systematic literature search was performed to identify relevant studies.
- Eighteen studies comprising 3419 psoriasis patients and 3297 healthy controls were included.
- Pooled odds ratios (OR) and 95% confidence intervals (95%CI) were calculated to assess the association.
Main Results:
- Significant associations were found between HLA-Cw*0602 polymorphism and psoriasis risk across various genetic models.
- Positive versus negative alleles: OR = 4.55, 95%CI = 3.65-5.67, P < 0.00001.
- Positive homozygote versus negative homozygote: OR = 23.03, 95%CI = 13.95-38.00, P < 0.00001.
Conclusions:
- The positive allele of HLA-Cw*0602 polymorphism is a significant risk factor for psoriasis.
- This finding supports the role of specific HLA alleles in the genetic susceptibility to psoriasis.
- Further research may explore the functional mechanisms linking HLA-Cw*0602 to psoriasis pathogenesis.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...